FOXO1 and cancer: Since MELK could directly phosphorylate FOXO1 and FOXO3, our results further implied that effective restoration of these transcriptional factors by OTS167 treatment may be one of the important pathways to suppress proliferation of the p53-deficient cancer cells by MELK inhibition.